These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 15036420

  • 1. The IL-6 -174G>C polymorphism is associated with cardiovascular diseases and mortality in 80-year-old humans.
    Bruunsgaard H, Christiansen L, Pedersen AN, Schroll M, Jørgensen T, Pedersen BK.
    Exp Gerontol; 2004 Feb; 39(2):255-61. PubMed ID: 15036420
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK, Kim OY, Koh SJ, Jang Y, Chae JS, Kim JY, Kim HJ, Hyun YJ, Cho JR, Lee JH.
    Clin Chim Acta; 2007 May 01; 380(1-2):68-74. PubMed ID: 17335789
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The -174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing.
    Giacconi R, Cipriano C, Albanese F, Boccoli G, Saba V, Olivieri F, Franceschi C, Mocchegiani E.
    Exp Gerontol; 2004 Apr 01; 39(4):621-8. PubMed ID: 15050298
    [Abstract] [Full Text] [Related]

  • 8. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, Rindi P, Donati G, Antonelli A, Panicucci E, Tripepi G, Tetta C, Palla R, RISCAVID Study Group.
    Nephrol Dial Transplant; 2008 Jul 01; 23(7):2337-43. PubMed ID: 18305316
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study.
    Sayed-Tabatabaei FA, Schut AF, Arias Vásquez A, Bertoli-Avella AM, Hofman A, Witteman JC, van Duijn CM.
    J Med Genet; 2005 Jan 01; 42(1):26-30. PubMed ID: 15635071
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking.
    Panoulas VF, Stavropoulos-Kalinoglou A, Metsios GS, Smith JP, Milionis HJ, Douglas KM, Nightingale P, Kitas GD.
    Atherosclerosis; 2009 May 01; 204(1):178-83. PubMed ID: 18848327
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
    Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C.
    J Rheumatol; 2006 Apr 01; 33(4):703-8. PubMed ID: 16583473
    [Abstract] [Full Text] [Related]

  • 15. Influence of the IL-6 -572C>G polymorphism on inflammatory markers according to cigarette smoking in Korean healthy men.
    Shin KK, Jang Y, Koh SJ, Chae JS, Kim OY, Park S, Choi D, Shin DJ, Kim HJ, Lee JH.
    Cytokine; 2007 Aug 01; 39(2):116-22. PubMed ID: 17689974
    [Abstract] [Full Text] [Related]

  • 16. Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis.
    Sie MP, Sayed-Tabatabaei FA, Oei HH, Uitterlinden AG, Pols HA, Hofman A, van Duijn CM, Witteman JC.
    Arterioscler Thromb Vasc Biol; 2006 Jan 01; 26(1):212-7. PubMed ID: 16269662
    [Abstract] [Full Text] [Related]

  • 17. Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal Aging Study Amsterdam.
    Schalk BW, Visser M, Bremmer MA, Penninx BW, Bouter LM, Deeg DJ.
    Am J Epidemiol; 2006 Nov 15; 164(10):969-77. PubMed ID: 16980573
    [Abstract] [Full Text] [Related]

  • 18. Impact of interleukin 6 -174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight.
    Goyenechea E, Parra D, Martínez JA.
    Metabolism; 2007 Dec 15; 56(12):1643-8. PubMed ID: 17998015
    [Abstract] [Full Text] [Related]

  • 19. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort.
    Sekuri C, Cam FS, Sagcan A, Ercan E, Tengiz I, Alioglu E, Berdeli A.
    Coron Artery Dis; 2007 Aug 15; 18(5):333-7. PubMed ID: 17627181
    [Abstract] [Full Text] [Related]

  • 20. The interleukin-6 -174 G>C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients.
    Antonicelli R, Olivieri F, Bonafè M, Cavallone L, Spazzafumo L, Marchegiani F, Cardelli M, Recanatini A, Testarmata P, Boemi M, Parati G, Franceschi C.
    Int J Cardiol; 2005 Sep 01; 103(3):266-71. PubMed ID: 16098388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.